The "minimal initial benefit" group (approximately 5-10% of users) reported limited improvements during treatment making discontinuation effects irrelevant, typically explained by inadequate product quality with degraded or low-concentration GHK-Cu, inappropriate application technique reducing absorption, unrealistic expectations exceeding what any topical can achieve, severe underlying pathology requiring medical intervention beyond cosmetic peptides, or individual non-responsiveness to copper peptide treatment for genetic or physiological reasons
Headache Headaches are reported by some people using Albuterol
However, they work through different mechanisms and can complement each other when used thoughtfully
If you started at the higher end and experienced problems, reduce to 0.5mg to 1mg daily
Continuing treatment for two to four weeks beyond initial improvement helps ensure tissue has fully healed rather than just reaching a pain-free but fragile state
Key Takeaways 5-Amino-1MQ is a small molecule that inhibits the NNMT enzyme, a regulator studied in cellular energy and methylation pathways